Meridian Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261K | Hold |
800
| – | – | 0.17% | 102 |
|
|
2025
Q1 | $216K | Sell |
800
-100
| -11% | -$27K | 0.15% | 111 |
|
|
2024
Q4 | $212K | Hold |
900
| – | – | 0.15% | 110 |
|
|
2024
Q3 | $248K | Hold |
900
| – | – | 0.17% | 111 |
|
|
2024
Q2 | $219K | Buy |
+900
| New | +$219K | 0.16% | 117 |
|
|
2023
Q3 | – | Sell |
-1,234
| Closed | -$234K | – | 95 |
|
|
2023
Q2 | $234K | Hold |
1,234
| – | – | 0.21% | 87 |
|
|
2023
Q1 | $247K | Buy |
+1,234
| New | +$247K | 0.24% | 82 |
|